NCT00020449View on ClinicalTrials.gov

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Study Completion Date

May 31, 2004

Conditions
Sarcoma
Interventions
BIOLOGICAL

recombinant interleukin-12

DRUG

paclitaxel

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00020449 - Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter